Slides: Expanding therapeutic options for lowering LDL-c: Where will bempedoic acid and inclisiran contribute?
Slides as educational service to PACE members and meeting participants.
This lecture by Prof. Christie Ballantyne was part of a EBAC-accredited symposium "Redefining intensive LDL-c management in high CV risk patients - The case for combination therapy" held during ESC Congress 2021.
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: